ROYALTY PHARMA PLC- CL A (RPRX)       43.85  -0.19 (-0.43%)

43.85  -0.19 (-0.43%)

GB00BMVP7Y09 - Common Stock - After market: 43.85 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
2.25B2.29B2.12B1.81B1.79B
Non Recurring Items
N/AN/A-30.50MN/AN/A
Minority Interest Expense
-386.94M-621.47M-726.90M-112.90M-140.10M
Operating Expenses
1.30B858.75M527.00M-808.90M430.40M
Interest Expense
-30.96M-183.84M139.40M-162.20M154.90M
Income Before Taxes
893.76M1.24B1.70B2.46B1.52B
Income Tax
0.000.000.000.000.00
Net Income
506.82M619.73M975.00M2.35B1.38B
 
Per Share Data
EPS Diluted Total Ops
0.841.492.603.942.31
Non GAAP EPS
2.912.23N/AN/AN/A
 
Statistics
Profit Margin
22.55%27.07%45.94%129.44%76.76%

All data in USD

Charts